For real world
clinical practice
$9.95
The Val-HeFT Trial: Valsartan reduces morbidity in chronic heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:15 minutes
CPD 0.25
Free
Use of Remote Speech Analysis to Predict Worsening Heart Failure Events in Ambulatory Heart Failure Patients
This is a Module from the Course
By Professor William T. Abraham, M.D. on behalf of co-authors and The CordioHearO™Community Study Group
Expected time:15 minutes
Free
Was it always radial first?
This is a Module from the Course
By Sunil V. Rao, MD, Duke Clinical Research Institute
Expected time:30 minutes
CPD 0.5
Free
What Clinical Trials are Needed to Support MCS in the Modern Era?
Expected time:30 minutes
CPD 0.5
Free
What doctors don't know about the drugs they prescribe - TED Talk on Publication Bias
This is a Module from the Course
By Dr Ben Goldacre
Expected time:30 minutes
CPD 1.0
Free
What's new in Spinal Muscular Atrophy (SMA)
This is a Module from the Course
By Dr. Erin Neil
Expected time:1 hour
Free
What's new in Spinal Muscular Atrophy (SMA)
This is a Module from the Course
By Dr. Erin Neil
Expected time:45 minutes
CPD 0.25
Free
When both silent AF and PFO are discovered, the optimal therapy to prevent stroke recurrence is...?
Expected time:15 minutes
CPD 0.25
Free
With a hypercoagulable condition, is PFO closure more important, more dangerous or both?
Expected time:15 minutes
CPD 0.25
Free
Working around/through PFO closure devices for left-sided procedures
Expected time:15 minutes